Oventus Medical Ltd (ASX:OVN) is pleased to announce it has entered into a world-wide distribution agreement with Hong Kong based Modern Dental Group (HKG:3600). This is in addition to the recent announcement of the co-manufacturing agreement between Oventus and Modern Dental.
Wilsons maintain a BUY rating and $1.66 price target. Anatara's recent stock underperformance has simply reflected a slow quarter for news in the lead-up to a significant inflection point in the 2H.
Oventus Medical Ltd (ASX:OVN) is pleased to announce that low pressure CPAP without a mask is one step closer. Results from the initial pilot study generated significant interest when presented at the American Academy of Dental Sleep Medicine in Boston on June 2nd 2017. The conference is the premier world forum for the latest developments in dental sleep medicine.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide investors with an update on recent progress.
It has come the attention of Queensland Bauxite Ltd (ASX:QBL) that there has been some confusion between Andrew Kavasilas of Medical Cannabis Limited and Andrew Katelaris. Andrew Katelaris, Dr Pot, allegedly caught last week with cash and cannabis, and consequently arrested, is NOT the Andrew Kavasilas of Medical Cannabis Limited.
Oventus Medical Ltd (ASX:OVN) are pleased to announce that C-PAP (Continuous Positive Airway Pressure) without a mask is one step closer signalling the first major change in sleep medicine in decades. The first patient has been recruited in the next stage of a trial combining an oral appliance and C-PAP.
Regeneus Ltd (ASX:RGS) is pleased to provide the Company's latest presentation to ChinaBio Partnering Forum.
